The estimated Net Worth of John J Jr Huntz is at least $23.2 Millón dollars as of 30 August 2023. Mr. Huntz owns over 11,815 units of Manhattan Associates stock worth over $14,236,100 and over the last 21 years he sold MANH stock worth over $8,571,826. In addition, he makes $383,460 as Independent Chairman of the Board at Manhattan Associates.
John has made over 24 trades of the Manhattan Associates stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 11,815 units of MANH stock worth $2,397,854 on 30 August 2023.
The largest trade he's ever made was exercising 44,150 units of Manhattan Associates stock on 31 October 2012 worth over $1,184,986. On average, John trades about 2,400 units every 58 days since 2003. As of 30 August 2023 he still owns at least 53,096 units of Manhattan Associates stock.
You can see the complete history of Mr. Huntz stock trades at the bottom of the page.
John J. Huntz, Jr., is an Independent Chairman of Board of Manhattan Associates, Inc. Mr. Huntz has more than 35 years of private equity, venture capital, and operational experience. Since 2013, Mr. Huntz has served as Managing Director of Huntz & Co., LLC, a venture advisory firm. He also serves on several early stage technology and healthcare ventures boards and is an Advisor to Balentine, an Atlanta based wealth management firm. From 2005 to 2013, Mr. Huntz served as Executive Director, Venture Capital Investments, of Arcapita, Inc., and from 2009 to 2013, served as its President. From 2006 until 2010, Mr. Huntz also served as a director and Chairman of the Audit Committee of CardioMEMS, Inc., and then until 2014, he served as its Chairman of the Board. CardioMEMS was acquired by St. Jude Medical in 2014. From 1994 through 2005, Mr. Huntz worked at the Fuqua Companies, most recently as Managing Director of Fuqua Ventures. Mr. Huntz also served as Executive Vice President and Chief Operating Officer of Fuqua Enterprises, Inc., (NYSE) a public company. Mr. Huntz’ prior experience includes, from September 1989 to January 1994, serving as Managing Partner of Noble Ventures International, a private equity firm. From 1984 to 1989, Mr. Huntz provided financial and investment management consulting as Director of Capital Resources for Arthur Young & Company, and from 1979 to 1984, he was an investment professional at Harrison Capital, a private equity investment subsidiary of Texaco.
As the Independent Chairman of the Board of Manhattan Associates, the total compensation of John Huntz at Manhattan Associates is $383,460. There are 9 executives at Manhattan Associates getting paid more, with Eddie Capel having the highest compensation of $9,186,520.
John Huntz is 69, he's been the Independent Chairman of the Board of Manhattan Associates since 2003. There are no older and 17 younger executives at Manhattan Associates.
John's mailing address filed with the SEC is 2300 WINDY RIDGE PARKWAY, 10TH FLOOR, ATLANTA, GA, 30339.
Over the last 22 years, insiders at Manhattan Associates have traded over $137,707,215 worth of Manhattan Associates stock. The most active insiders traders include Ramesh Srinivasan, Peter F Sinisgalli y Peter J Kight. On average, Manhattan Associates executives and independent directors trade stock every 25 days with the average trade being worth of $4,760,739. The most recent stock trade was executed by Bruce Richards on 28 August 2024, trading 4,000 units of MANH stock currently worth $1,044,000.
for more than 25 years we have earned a reputation for building technology solutions that solve the most complex business problems in supply chain, inventory and omni-channel.
Manhattan Associates executives and other stock owners filed with the SEC include: